SAN MATEO, Calif.–(BUSINESS WIRE)–APRIL 2, 2019– InClin, Inc., a full-service Clinical Research Organization (CRO) with offices in the San Francisco Bay Area and Sydney Australia, today announced the appointment of Tara Weihmiller as Vice President of Clinical Operations. Ms. Weihmiller will be responsible for managing clinical staff and developing initiatives to support operational excellence. Additionally, Ms. Weihmiller will provide strategic direction for InClin and provide direct oversight on key clinical studies across various indications, including oncology.
“We are excited to welcome Tara as our Vice President of Clinical Operations,” said Brian Horger, Ph.D., Chief Executive Officer of InClin. “Her extensive clinical background makes her a perfect addition to the InClin team and reinforces our expertise in oncology. Tara’s knowledge and hands-on experience on both the sponsor- and CRO-sides make her an ideal fit with our mission to provide high-functioning partnerships with our sponsors to bring novel therapeutic agents to market.”
Ms. Weihmiller has over 20 years of experience working in the CRO, biotechnology and pharmaceutical industries, both in project management and global line management. She is a noted global operations leader with a solid reputation for delivering inventive operational strategies and client-focused solutions. Ms. Weihmiller has provided oversight to numerous Phase 1 to 4 clinical trials across multiple therapeutic areas including Oncology, Respiratory, Neurology, Infectious Disease, Dermatology, and Transplantation.
Prior to InClin, Ms. Weihmiller was the Executive Director of Global Portfolio Oversight for the Oncology Business Unit at Covance. She was also a Director of Clinical Operations at Novartis with responsibility for oversight and timely delivery of 120+ clinical trials with compounds for Hematology and Solid Tumor indications. She received her BS in Science Biology at the University of Albany.
InClin is a full-service Contract Research Organization (CRO) with offices in the San Francisco Bay Area and Sydney, Australia. We are a single source provider of an integrated full suite of clinical development services from Phase 1 to Phase 4, including project management, clinical monitoring, site and contract management, vendor management, data management, biostatistics, programming, drug safety, medical monitoring, medical writing, QA inspection readiness, as well as strategic consulting services. For more information visit www.InClin.com or contact us at firstname.lastname@example.org.
Office Phone: (650) 376-4086